Literature DB >> 31346866

Magnetic Resonance Imaging in Assessment of Cardiac Remodeling in Rats with Experimental Arterial Hypertension.

I G Agafonova1, V N Kotel'nikov2, B I Geltser2.   

Abstract

Magnetic resonance imaging was employed to examine the morphofunctional status of myocardium in Wistar rats with multifactor cardiovasorenal model of arterial hypertension. In 3 months after the onset of experiment, the rats demonstrated a pronounced hypertrophy in left ventricular myocardium mostly due to thickening of the posterior and lateral walls against the background of relatively stable thickness of ventricular septum. The left ventricular endsystolic volume markedly increased in parallel with moderate increase of the end-diastolic volume. The standard calculated indices were used for precise assessment of the type of remodeling of individual myocardial structures. The study showed that multifactor arterial hypertension model was characterized by domination of hypertrophic mode of the left ventricular remodeling, whereas the concentric variant was observed more rarely by 2.5 times. The greatest alterations were observed in the posterior and lateral walls of the left ventricle, which could result from the hemodynamic effects of hypervolemic arterial hypertension.

Entities:  

Keywords:  arterial hypertension; cardiac remodeling; magnetic resonance imaging; rat

Year:  2019        PMID: 31346866     DOI: 10.1007/s10517-019-04518-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Identification of Target Genes in Hypertension and Left Ventricular Remodeling.

Authors:  Bo Pang; Cong Hu; Guodong Wu; Yanli Zhang; Guangzhu Lin
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

2.  Estimation of the Morphofunctional Status of the Brain in Hypertensive Wistar Rats Using Diffusion-Weighted MRI.

Authors:  I G Agafonova; V N Kotelnikov; B I Geltcer
Journal:  Bull Exp Biol Med       Date:  2021-06-26       Impact factor: 0.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.